Waist circumference as a predictor of adiponectin levels in peritoneal dialysis patients: A 12-month follow-up study

Peritoneal Dialysis International

Volumn 33, Issue 2, 2013, Pages 182-188

  Bazanelli, Ana Paula ^a   Kamimura, Maria Ayako ^a   Canziani, Maria Eugenia Fernandes ^a   Manfredi, Silvia Regina ^a   Cuppari, Lilian ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Abdominal obesity; Adipokines; Waist circumference

Indexed keywords

ADIPONECTIN;

ADULT; ARTICLE; BODY MASS; BRAZIL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; OBESITY; PATIENT ASSESSMENT; PERITONEAL DIALYSIS; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; WAIST CIRCUMFERENCE;

ABDOMINAL FAT; ADIPONECTIN; ADIPOSITY; ADULT; AGED; BRAZIL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; TIME FACTORS; WAIST CIRCUMFERENCE;

EID: 84879003351     PISSN: 08968608     EISSN: 17184304     Source Type: Journal    
DOI: 10.3747/pdi.2011.00129     Document Type: Article

References (37)

1. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995; 270:26746-9.
2. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999; 257:79-83.
3. Matsubara M, Maruoka S, Katayose S. Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. Eur J Endocrinol 2002; 147:173-80.
4. Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003; 46:459-69.
5. Guebre-Egziabher F, Bernhard J, Funahashi T, Hadj-Aissa A, Fouque D. Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function. Nephrol Dial Transplant 2005; 20:129-34.
6. Stenvinkel P, Marchlewska A, Pecoits-Filho R, Heimbürger O, Zhang Z, Hoff C, et al. Adiponectin in renal disease: relationship to phenotype and genetic variation in the gene encoding adiponectin. Kidney Int 2004; 65:274-81.
7. Tsao YT, Hsu YJ, Chu NF, Lai CH, Chiu JS, Lin SH. Association of plasma adiponectin and cardiovascular risk profiles in nondiabetic uremic patients on peritoneal dialysis. J Nephrol 2008; 21:744-52.
8. Odamaki M, Furuya R, Kinumura Y, Ikegaya N, Kumagai H. Association between plasma adiponectin concentration and visceral fat accumulation in hemodialysis patients. Nephron Clin Pract 2006; 102:c8-13.
9. Yang WS, Chen MH, Lee WJ, Lee KC, Chao CL, Huang KC, et al. Adiponectin mRNA levels in the abdominal adipose depots of nondiabetic women. Int J Obes Relat Metab Disord 2003; 27:896-900.
10. Zoccali C, Postorino M, Marino C, Pizzini P, Cutrupi S, Tripepi G on behalf of the CREDIT Working Group. Waist circumference modifies the relationship between the adipose tissue cytokines leptin and adiponectin and all-cause and cardiovascular mortality in haemodialysis patients. J Intern Med 2011; 269:172-81.
11. Stewart KJ, DeRegis JR, Turner KL, Bacher AC, Sung J, Hees PS, et al. Usefulness of anthropometrics and dual-energy X-ray absorptiometry for estimating abdominal obesity measured by magnetic resonance imaging in older men and women. J Cardiopulm Rehabil 2003; 23:109-14.
12. Després JP, Prud'homme D, Pouliot MC, Tremblay A, Bouchard C. Estimation of deep abdominal adipose-tissue accumulation from simple anthropometric measurements in men. Am J Clin Nutr 1991; 54:471-7.
13. Janssen I, Heymsfield SB, Allison DB, Kotler DP, Ross R. Body mass index and waist circumference independently contribute to the prediction of nonabdominal, abdominal subcutaneous, and visceral fat. Am J Clin Nutr 2002; 75:683-8.
14. Vega GL, Adams-Huet B, Peshock R, Willett D, Shah B, Grundy SM. Influence of body fat content and distribution on variation in metabolic risk. J Clin Endocrinol Metab 2006; 91:4459-66.
15. Sanches FM, Avesani CM, Kamimura MA, Lemos MM, Axelsson J, Vasselai P, et al. Waist circumference and visceral fat in CKD: a cross-sectional study. Am J Kidney Dis 2008; 52:66-73.
16. Bazanelli AP, Kamimura MA, Manfredi SR, Draibe SA, Cuppari L. Usefulness of waist circumference as a marker of abdominal adiposity in peritoneal dialysis: a cross-sectional and prospective analysis. Nephrol Dial Transplant 2012; 27:790-5.
17. Fernström A, Hylander B, Moritz A, Jacobsson H, Rössner S. Increase of intra-abdominal fat in patients treated with continuous ambulatory peritoneal dialysis. Perit Dial Int 1998; 18:166-71.
18. Choi SJ, Kim NR, Hong SA, Lee WB, Park MY, Kim JK, et al. Changes in body fat mass in patients after starting peritoneal dialysis. Perit Dial Int 2011; 31:67-73.
19. Keys A, Aravanis C, Blackburn H, Van Buchem FS, Buzina R, Djordjevic BS, et al. Probability of middle-aged men developing coronary heart disease in five years. Circulation 1972; 45:815-28.
20. Churchill DN, Taylor DW, Keshaviah PR, and the CANUSA Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. J Am Soc Nephrol 1996; 7:198-207.
21. Twardowski ZJ. Clinical value of standardized equilibration tests in CAPD patients. Blood Purif 1989; 7:95-108.
22. Adamczak M, Chudek J, Wiecek A. Adiponectin in patients with chronic kidney disease. Semin Dial 2009; 22:391-5.
23. Adamczak M, Rzepka E, Chudek J, Wiecek A. Ageing and plasma adiponectin concentration in apparently healthy males and females. Clin Endocrinol (Oxf) 2005; 62:114-18.
24. Mallamaci F, Zoccali C, Cuzzola F, Tripepi G, Cutrupi S, Parlongo S, et al. Adiponectin in essential hypertension. J Nephrol 2002; 15:507-11.
25. Nanayakkara PW, Le Poole CY, Fouque D, van Guldener C, Stehouwer CD, Smulders YM, et al. Plasma adiponectin concentration has an inverse and a non linear association with estimated glomerular filtration rate in patients with K/DOQI 3 - 5 chronic kidney disease. Clin Nephrol 2009; 72:21-30.
26. Yu ZZ, Ni ZH, Gu LY, Lin AW, Fang W, Yao Q, et al. Adiponectin is related to carotid artery plaque and a predictor of cardiovascular outcome in a cohort of non-diabetic peritoneal dialysis patients. Blood Purif 2008; 26:386-93.
27. Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S, et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 2002; 13:134-41.
28. Ignacy W, Chudek J, Adamczak M, Funahashi T, Matsuzawa Y, Kokot F, et al. Reciprocal association of plasma adiponectin and serum C-reactive protein concentration in haemodialysis patients with end-stage kidney disease-a follow-up study. Nephron Clin Pract 2005; 101:c18-24.
29. Huang JW, Yen CJ, Chiang HW, Hung KY, Tsai TJ, Wu KD. Adiponectin in peritoneal dialysis patients: a comparison with hemodialysis patients and subjects with normal renal function. Am J Kidney Dis 2004; 43:1047-55.
30. Lu Q, Cheng LT, Wang T, Wan J, Liao LL, Zeng J, et al. Visceral fat, arterial stiffness, and endothelial function in peritoneal dialysis patients. J Ren Nutr 2008; 18:495-502.
31. Wang CH, Wang JH, Lee CJ, Fang TC, Liou HH, Hsu BG. Fasting serum adiponectin level inversely correlates with metabolic syndrome in peritoneal dialysis patients. Blood Purif 2010; 30:1-7.
32. Axelsson J, Heimbürger O, Lindholm B, Stenvinkel P. Adipose tissue and its relation to inflammation: the role of adipokines. J Ren Nutr 2005; 15:131-6.
33. Becker B, Kronenberg F, Kielstein JT, Haller H, Morath C, Ritz E, et al. Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: the mild and moderate kidney disease study. J Am Soc Nephrol 2005; 16:1091-8.
34. Iwashima Y, Horio T, Kumada M, Suzuki Y, Kihara S, Rakugi H, et al. Adiponectin and renal function, and implication as a risk of cardiovascular disease. Am J Cardiol 2006; 98:1603-8.
35. Rao M, Li L, Tighiouart H, Jaber BL, Pereira BJ, Balakrishnan VS on behalf of the HEMO Study Group. Plasma adiponectin levels and clinical outcomes among haemodialysis patients. Nephrol Dial Transplant 2008; 23:2619-28.
36. Menon V, Li L, Wang X, Greene T, Balakrishnan V, Madero M, et al. Adiponectin and mortality in patients with chronic kidney disease. J Am Soc Nephrol 2006; 17:2599-606.
37. Ohashi N, Kato A, Misaki T, Sakakima M, Fujigaki Y, Yamamoto T, et al. Association of serum adiponectin levels with all-cause mortality in hemodialysis patients. Intern Med 2008; 47:485-91.